chr20-43515054-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001377303.1(L3MBTL1):c.548C>T(p.Pro183Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00106 in 1,614,014 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001377303.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L3MBTL1 | NM_001377303.1 | c.548C>T | p.Pro183Leu | missense_variant | 5/22 | ENST00000418998.7 | NP_001364232.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L3MBTL1 | ENST00000418998.7 | c.548C>T | p.Pro183Leu | missense_variant | 5/22 | 2 | NM_001377303.1 | ENSP00000398516.2 | ||
ENSG00000288000 | ENST00000657241.1 | c.1229C>T | p.Pro410Leu | missense_variant | 9/26 | ENSP00000499734.1 |
Frequencies
GnomAD3 genomes AF: 0.000611 AC: 93AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000541 AC: 136AN: 251250Hom.: 0 AF XY: 0.000464 AC XY: 63AN XY: 135812
GnomAD4 exome AF: 0.00110 AC: 1611AN: 1461800Hom.: 3 Cov.: 32 AF XY: 0.00106 AC XY: 774AN XY: 727204
GnomAD4 genome AF: 0.000611 AC: 93AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.000498 AC XY: 37AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.482C>T (p.P161L) alteration is located in exon 5 (coding exon 4) of the L3MBTL1 gene. This alteration results from a C to T substitution at nucleotide position 482, causing the proline (P) at amino acid position 161 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at